Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
The top drug regulator at the US Food and Drug Administration (FDA) said the agency is working to develop new pathways for ...
Indian lawmakers have voted to decriminalize some compliance breaches to reduce regulatory litigation burden, eliminating the ...
The US Food and Drug Administration (FDA) has notified more than 2,200 medical product manufacturers and researchers to ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
The International Medical Device Regulators Forum (IMDRF) has released a draft technical document to create a harmonized set ...
Many of the bispecific antibodies (BsAbs) approved by global regulators have yet to demonstrate robust clinical benefit ...
A European Medicines Agency (EMA) group has recommended actions the regulator and industry can take to accelerate regulatory ...
E22 guideline should incorporate caregiver feedback, according to responses submitted by industry groups and manufacturers to ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results